| SDYYX | VFINX | SDYYX / VFINX | |
| Total Expense Ratio | 0.50 | 0.14 | 357% |
| Annual Report Gross Expense Ratio | 0.93 | 0.14 | 664% |
| Fund Existence | 11 years | 50 years | - |
| Gain YTD | 8.870 | 9.459 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 837M | 1.67T | 0% |
| Annual Yield % from dividends | 1.60 | 0.97 | 166% |
| Returns for 1 year | 0.01 | 18.18 | 0% |
| Returns for 3 years | 18.78 | 63.86 | 29% |
| Returns for 5 years | 7.07 | 70.57 | 10% |
| Returns for 10 years | 122.13 | 247.72 | 49% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SLGCX | 1.97 | 0.01 | +0.51% |
| Saratoga Large Capitalization Growth C | |||
| BERIX | 14.38 | -0.01 | -0.07% |
| Carillon Chartwell Real Income I | |||
| PCCGX | 12.40 | -0.03 | -0.24% |
| Victory Pioneer Mid Cap Value C | |||
| ERSMX | 29.37 | -0.20 | -0.68% |
| Eaton Vance Atlanta Capital SMID-Cap R | |||
| FBTCX | 34.49 | -0.83 | -2.35% |
| Fidelity Advisor Biotechnology C | |||